Skip to content
Abierto
Menu

Award notice, first published as solicitation

2026 NIAID DMID Omnibus Broad Agency Announcement

HHS-NIH-NIAID-BAA2025-1

National Institutes of Health, National Institutes of Health Niaid. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

View on SAM.govMarkdown

Awarded

Zepto Life Technology, Inc.

$23,878,987.00 on the award notice, July 29, 2026, contract 75N93026C00012

Description

As published on SAM.gov.

This cost-reimbursement contract award was made under full and open competition. This type of contract was selected because costs cannot be adequately defined at the time of contract award.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Zepto Life Technology, Inc.
UEI
ELTELWNJZJ73
CAGE
762N0
Vendor location
Saint Paul, MN
Contract
75N93026C00010, definitive contract
Obligated
$1,878,981.00, potential $8,946,929
Actions
1 between July 17, 2026 and July 17, 2026
Competition
Full and Open Competition, 7 offers received
Set-aside reported
No Set Aside Used.
Described as
To Develop and Clinically Validate an Innovative Cell-Free Deoxyribonucleic Acid (Cfdna) Based Panel for Detecting Disease-Causing Fungi Directly from Plasma.
Match
solicitation number HHSNIHNIAIDBAA20251 equals the FPDS solicitation identifier; same awarding office 75N930 (high confidence)
Record
USAspending award page
Recipient
Arisan Therapeutics Inc.
UEI
PYRKTQPNVJZ8
CAGE
616D2
Vendor location
Carlsbad, CA
Contract
75N93026C00012, definitive contract
Obligated
$2,933,547.00, potential $23,878,987
Actions
1 between July 29, 2026 and July 29, 2026
Competition
Full and Open Competition, 20 offers received
Set-aside reported
No Set Aside Used.
Described as
To Develop a Therapeutic Small Molecule Viral Entry Inhibitor as a Medical Countermeasure for Filovirus Infection.
Match
award number 75N93026C00012 equals the contract number; same awarding office 75N930 (high confidence)
Record
USAspending award page
Recipient
University of Tennessee
UEI
X1M1PN3KG3E7
CAGE
1BW75
Vendor location
Memphis, TN
Contract
75N93026C00013, definitive contract
Obligated
$1,851,661.00, potential $9,349,598
Actions
1 between August 3, 2026 and August 3, 2026
Competition
Full and Open Competition, 20 offers received
Set-aside reported
No Set Aside Used.
Described as
To Conduct Investigational New Drug (Ind)-Enabling Studies of a Pre-Clinical Candidate for the Treatment of Neurotropic Alphaviruses.
Match
solicitation number HHSNIHNIAIDBAA20251 equals the FPDS solicitation identifier; same awarding office 75N930 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. January 10, 2025

    Solicitation

    Due January 21, 2025 at 3:00 PM EST. SAM.gov, notice 71678fe667d04994b7b3457112f269a2

  2. January 16, 2025

    Solicitation

    Due February 21, 2025 at 3:00 PM EST. SAM.gov, notice 44a2b2c9f0c04ba09a1365281b912b1b

  3. July 17, 2026

    Award notice, originally solicitation

    Awarded to ZEPTO LIFE TECHNOLOGY, Inc. Saint Paul for $8,946,929. SAM.gov, notice 8641633670c24be78907b2010a02935c

  4. August 3, 2026

    Award notice, originally solicitation

    Awarded to UNIVERSITY OF TENNESSEE Memphis for $9,349,598. SAM.gov, notice 933e442e3d3c401e96446236109997d3

  5. August 3, 2026

    Award notice, originally solicitation

    Awarded to ARISAN THERAPEUTICS Inc. Carlsbad for $23,878,987. SAM.gov, notice e33401d149fe42e9bf8ce366c9ca0f50

Points of contact

Also open from this buyer